<DOC>
	<DOC>NCT02445755</DOC>
	<brief_summary>The purpose of this study is to test the performance of a new transcutaneous ("measured through skin") bilirubin device (BiliCare™) to measure bilirubin levels. The investigators plan to evaluate the clinical performance of this device as a point of care test. If the investigators can validate the BiliCare™ with bilirubin from your baby's blood they could verify a non-invasive alternative for measuring bilirubin.</brief_summary>
	<brief_title>Transcutaneous Bilirubinometry in Neonates With the Bilicare System</brief_title>
	<detailed_description />
	<criteria>1. Parental informed consent 2. Male and female newborns with a GA ≥ 35 wks 3. Enrollment at age &gt; 6 hrs until neonatal discharge 4. Prephototherapy 1. Infants requiring respiratory assistance (such as mechanical ventilation) 2. Severe or lifethreatening congenital anomalies 3. Hematomas at the point of measurement on both ears 4. Neonates undergone blood transfusion</criteria>
	<gender>All</gender>
	<minimum_age>35 Weeks</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Neonates</keyword>
	<keyword>Bilicare System</keyword>
</DOC>